Analyst ratings
11 analysts have weighed in: a Strong Buy consensus: 10 buy calls against 0 sell, with an average 12-month price target of $20.82.
NASDAQ: BCRX · Drug Manufacturers - Specialty & Generic
Over the past week, Biocryst Pharmaceuticals (BCRX) logged 12 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 100% bullish across the tracked sources. Wall Street is more cautious, with 10 of 11 analysts rating BCRX a buy.
There is little buzz around BCRX this week and broad agreement on direction, which is why it reads as a Buy.
Wall Street’s 91% buy share sits next to a crowd that ranges from News at 100% to Reddit at 100%. No other tracker puts the two side by side.
11 analysts have weighed in: a Strong Buy consensus: 10 buy calls against 0 sell, with an average 12-month price target of $20.82.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources broadly agree, so the read is a Buy.
The crowd runs 9 points hotter than the 91% analyst buy share, retail is ahead of the Street here. The split is inside the crowd: Reddit reads 100% bullish while News sits at 100%, a 0-point spread that single-source trackers miss.
Over the 30-day window, Biocryst Pharmaceuticals (BCRX) buzz held subdued around 26.6 while the price drifted up 7.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3M shares. Over the last 7 trading days, BCRX gained 0.9%. Buzz activity in the recent week averaged 24.9 and was relatively stable, swinging between 20.2 and 29.6. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 9 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for BCRX and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live BCRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (10 / 1 / 0) |
| Crowd bullish (7d) | 100% |
| Avg price target | $20.82 |
| Most bullish source | Reddit, 100% |
| Most bearish source | News, 100% |
| Sentiment spread | 0 pts |
| Mentions (7d) | 12 |
| Market cap | $2.58B |
| P/E · Forward P/E | n/a · 16.8 |
| EPS · Beta | -$1.40 · 0.6 |
| Revenue (TTM) | $940.6M · -41% margin |
| Industry | Drug Manufacturers - Specialty & Generic |
Based on aggregated sentiment from Reddit, X and News sources, Biocryst Pharmaceuticals (BCRX) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 100% bullish across 3 active sources. Those sources contribute 12 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Biocryst Pharmaceuticals (BCRX) is fairly quiet with 4 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bullish on Biocryst Pharmaceuticals (BCRX), averaging 100% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and News at 100%, a 0-point spread. On the professional side, 10 of 11 analysts rate BCRX a buy.
Of the 11 analysts covering Biocryst Pharmaceuticals (BCRX), 10 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $20.82. The crowd is the more bullish of the two, averaging 100%.
Biocryst Pharmaceuticals (BCRX)'s cross-source average is bullish at 100% bullish. All 3 tracked sources lean bullish. X reads 100% bullish, News reads 100% bullish and reddit coverage is the most negative at 100% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Biocryst Pharmaceuticals (BCRX) at 100% bullish. All 3 tracked sources lean bullish. The most bearish reading is reddit at 100% bullish. 3-day activity momentum is rising across Reddit. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 6 mentions (50% of total volume). Reddit contributes 4 mentions and X contributes 2 mentions. The cross-source average is bullish at 100% bullish, while reddit is the only source with rising 3-day activity. All 3 tracked sources lean bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. BCRX's buy signal at 93/100 conviction reflects a bullish cross-source average at 100% bullish. All 3 tracked sources lean bullish. It is a research shortcut, not financial advice.
The BCRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key